Plant mitochondrial genome engineering: technology development and application to study fundamental aspects of mitochondrial gene expression
PlaMitEng aims to enable genetic engineering of plant mitochondrial genomes through novel editing and transformation technologies, unlocking new research and biotechnology opportunities.
Projectdetails
Introduction
PlaMitEng has the highly ambitious overall objective to make the mitochondrial genome of seed plants amenable to genetic engineering.
Project Overview
The project consists of two complementary work packages (WPs).
WP1: TALEN-GDM
In WP1, TALEN-GDM, a technology for plant mitochondrial genome editing recently developed by us will be used to systematically study plant mitochondrial gene expression in vivo.
- The focus will be on:
- Translation initiation
- Translational regulation in mitochondria
The mechanisms of which are currently completely unknown.
WP2: Direct Genetic Transformation
In WP2, PlaMitEng will develop a technology for direct genetic transformation of the plant mitochondrial genome.
- The mitochondrial genome is the only genome of the plant cell that, due to the lack of a mitochondrion-specific selection system, is not amenable to transformation and has remained recalcitrant to the insertion and expression of transgenes.
Taking advantage of:
- Our recent construction of a mitochondrion-specific selectable marker gene
- The generation of a dedicated recipient line for mitochondrial transformation
- The design of a new transformation strategy (referred to as multivectorial transformation)
This will enable the large-scale testing of expression elements for their suitability to drive the expression of mitochondrial transgenes in vivo.
Future Opportunities
PlaMitEng will pursue the development of a robust technology for transformation of the plant mitochondrial genome. The possibility to express transgenes from plant mitochondrial genomes will open up entirely new opportunities in both basic and applied research, and pave the way to harnessing the enormous potential of mitochondrial biotechnology and synthetic biology.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.500.000 |
Totale projectbegroting | € 2.500.000 |
Tijdlijn
Startdatum | 1-7-2024 |
Einddatum | 30-6-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Mitochondrial gene eXpressionThis project aims to elucidate the mechanisms regulating mitochondrial gene expression by investigating transcript interactomes and translation dynamics in both organello and in vivo contexts. | ERC Advanced... | € 1.913.968 | 2023 | Details |
In planta jet injection: Efficient genetic engineering of resilient cropsThe project aims to develop affordable, high-throughput devices for efficient genome editing in crops to enhance yield and climate resilience, addressing global food security challenges by 2100. | ERC Proof of... | € 150.000 | 2023 | Details |
Developing technologies to engineer plant genomes at the megabase scaleThe OMEGA project aims to identify essential plant genes and develop Megabase-scale genome editing tools to enhance genomics and synthetic biology applications in plants. | ERC Starting... | € 1.496.250 | 2022 | Details |
Structural studies of the human mitochondrial RNA life cycleMitoRNA aims to elucidate the molecular mechanisms of mitochondrial RNA metabolism and gene expression coupling using integrated structural biology to advance mitochondrial biology understanding. | ERC Starting... | € 1.499.754 | 2024 | Details |
Biophysical Genetic Design Automation TechnologyThe PLATE project aims to create a modular software suite that integrates advanced biophysical models for accurate design of synthetic biology circuits, addressing context-dependency challenges for reliable applications. | ERC Proof of... | € 150.000 | 2022 | Details |
Mitochondrial gene eXpression
This project aims to elucidate the mechanisms regulating mitochondrial gene expression by investigating transcript interactomes and translation dynamics in both organello and in vivo contexts.
In planta jet injection: Efficient genetic engineering of resilient crops
The project aims to develop affordable, high-throughput devices for efficient genome editing in crops to enhance yield and climate resilience, addressing global food security challenges by 2100.
Developing technologies to engineer plant genomes at the megabase scale
The OMEGA project aims to identify essential plant genes and develop Megabase-scale genome editing tools to enhance genomics and synthetic biology applications in plants.
Structural studies of the human mitochondrial RNA life cycle
MitoRNA aims to elucidate the molecular mechanisms of mitochondrial RNA metabolism and gene expression coupling using integrated structural biology to advance mitochondrial biology understanding.
Biophysical Genetic Design Automation Technology
The PLATE project aims to create a modular software suite that integrates advanced biophysical models for accurate design of synthetic biology circuits, addressing context-dependency challenges for reliable applications.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cellsThis project aims to develop an automated high-throughput PEN photoporation system for safely and efficiently genetically modifying T cells and MSCs for cancer therapy commercialization. | EIC Transition | € 2.497.711 | 2024 | Details |
Next generation gene writing platform to cure genetic and oncological diseasesIntegra Therapeutics' FiCAT platform enhances gene therapy by enabling precise and safe insertion of large DNA sequences, aiming to cure genetic and cancer-related diseases. | EIC Accelerator | € 2.496.375 | 2024 | Details |
3P-Tec - Three-parent breeding technology for plants of the futureThe project aims to develop a revolutionary three-parent breeding technology (3P-Tec) to create climate-resilient crops, enhancing yields and accelerating the commercialization of improved seed varieties. | EIC Transition | € 2.498.828 | 2022 | Details |
Genetisch gemodificeerde micro-organismen op een bio-based dieetEV Biotech onderzoekt de haalbaarheid van genetisch gemodificeerde micro-organismen die zetmeel kunnen afbreken voor duurzame biomolecuulproductie, ter vervanging van dure glucose. | Mkb-innovati... | € 20.000 | 2023 | Details |
A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing systemThe NANO-ENGINE project aims to develop an affordable, scalable, and safe DNA-based in vivo cell programming technology using Targeted Nanoparticles to enhance accessibility of cell therapies for various diseases. | EIC Pathfinder | € 2.988.377 | 2023 | Details |
PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cells
This project aims to develop an automated high-throughput PEN photoporation system for safely and efficiently genetically modifying T cells and MSCs for cancer therapy commercialization.
Next generation gene writing platform to cure genetic and oncological diseases
Integra Therapeutics' FiCAT platform enhances gene therapy by enabling precise and safe insertion of large DNA sequences, aiming to cure genetic and cancer-related diseases.
3P-Tec - Three-parent breeding technology for plants of the future
The project aims to develop a revolutionary three-parent breeding technology (3P-Tec) to create climate-resilient crops, enhancing yields and accelerating the commercialization of improved seed varieties.
Genetisch gemodificeerde micro-organismen op een bio-based dieet
EV Biotech onderzoekt de haalbaarheid van genetisch gemodificeerde micro-organismen die zetmeel kunnen afbreken voor duurzame biomolecuulproductie, ter vervanging van dure glucose.
A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing system
The NANO-ENGINE project aims to develop an affordable, scalable, and safe DNA-based in vivo cell programming technology using Targeted Nanoparticles to enhance accessibility of cell therapies for various diseases.